Kingspan Group PLC
F:KRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Kingspan Group PLC
F:KRX
|
IE |
|
L
|
L&C Bio Co Ltd
KOSDAQ:290650
|
KR |
|
O
|
Origin Property PCL
SET:ORI
|
TH |
|
A
|
Asia Metal PCL
SET:AMC
|
TH |
|
Brunello Cucinelli SpA
MIL:BC
|
IT |
|
MongoDB Inc
NASDAQ:MDB
|
US |
|
S
|
Societe BIC SA
XMUN:BIF
|
FR |
|
Discovery Ltd
F:D3H
|
ZA |
|
L
|
LaserOptek Co Ltd
KOSDAQ:199550
|
KR |
|
Z
|
Zealand Pharma A/S
F:22Z
|
DK |
|
O
|
OSI Systems Inc
F:OS2
|
US |
|
E
|
Exelon Corp
F:PEO
|
US |
|
H
|
Heiwa Real Estate Co Ltd
DUS:HZJ
|
JP |
|
MEC Co Ltd
OTC:MECGF
|
JP |
|
A
|
Algorae Pharmaceuticals Ltd
OTC:LVCLF
|
AU |
|
T
|
Transurban Group
F:TU9
|
AU |
|
Vitura SA
PAR:VTR
|
FR |
|
B
|
Balfour Beatty PLC
F:BIH
|
UK |
|
G
|
Global Electrical Technology Corp
VN:GLT
|
VN |
|
3D Oil Ltd
ASX:TDO
|
AU |
|
C
|
CMS Edu Co Ltd
KOSDAQ:225330
|
KR |
|
Frontier Developments PLC
F:5FD
|
UK |
|
M
|
ManpowerGroup Inc
F:MPW
|
US |
Earnings Calls
Last Earnings Call
Strong first half: Kingspan said H1 revenue was just under EUR 4.9 billion, up 8%, with EBITDA up 9% and trading profit up 10%. Management described the result as strong despite a difficult first quarter globally.
Guidance raised: The company lifted full-year trading profit guidance to EUR 1.125 billion, implying about 25% second-half trading profit growth and revenue solidly above EUR 10 billion for the year.
Advances momentum: The data-center-focused Advances business was a standout, with revenue up 36% pre-currency. Management said 2026 EBITDA could be around EUR 400 million, well ahead of the earlier EUR 300 million expectation.
Margin outlook: Group trading margin was 10% in H1, up 20 basis points, and management expects close to 12% in H2, leaving full-year margin around 11% with further improvement into 2027.
Balance sheet discipline: Kingspan paused share buybacks to preserve flexibility for “chunky” acquisitions, but said it will not go beyond 2x leverage and has about EUR 1 billion of headroom today.
Demand trends: Insulated panels order intake rose 13% by volume globally, with strength in Iberia, France, Germany, North America, and Latin America. Management said the order book remains healthy into the second half.
IPO off table: Management said the Advances IPO discussion is over and that the business is firmly part of Kingspan, while still leaving room for future M&A within its balance-sheet limits.